Personalized breathing exercises for COPD patients
Investigation of the Effectiveness of Personalized Breathing Exercise Device in Patients With COPD
This study tests whether a personalized breathing exercise device can help people with COPD breathe better and feel stronger during activities.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 34 (estimated) |
| Ages | 40 Years to 65 Years |
| Sex | All |
| Sponsor | Istanbul University - Cerrahpasa Academic / other |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT06259188 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a personalized breathing exercise device designed for patients with Chronic Obstructive Pulmonary Disease (COPD). It focuses on respiratory muscle training, specifically combining inspiratory and expiratory muscle training to enhance pulmonary function, reduce dyspnea, and improve overall exercise capacity. The study aims to provide evidence on the benefits of this combined training approach compared to isolated training methods. Participants will be monitored for improvements in respiratory muscle strength and quality of life over the course of the intervention.
Who should consider this trial
Good fit: Ideal candidates are clinically stable COPD patients classified as B, C, or D according to GOLD criteria, who have been under medical supervision for at least six months.
Not a fit: Patients with a history of pneumothorax, unstable cardiac conditions, or those who have recently participated in another pulmonary rehabilitation program may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of life and respiratory function for COPD patients.
How similar studies have performed: Previous studies have shown positive outcomes with similar respiratory muscle training approaches, indicating potential for success in this study.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with COPD by a pulmonologist according to GOLD 2022 diagnostic criteria (GOLD, 2022) and in classes B, C and D according to GOLD * Followed for at least 6 months * Clinically stable patients without exacerbations or infections Exclusion Criteria: * Patients with a history of spontaneous or trauma-related pneumothorax * Patients with middle ear-related pathologies (such as tympanic membrane rupture, otitis) * Orthopedic and neurological problems that may interfere with exercise training * Changes in medical treatment during the study * Patients with unstable concomitant cardiac disease * Patients who have been involved in another pulmonary rehabilitation program within the last 6 months * Insufficient cooperation
Where this trial is running
Istanbul
- Istanbul University-Cerrahpasa — Istanbul, Turkey (Recruiting)
Study contacts
- Principal investigator: Ozge Ertan — Istanbul University - Cerrahpasa
- Study coordinator: Ozge Ertan
- Email: ozge.ertann@gmail.com
- Phone: +902124141500
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.